A pleural effusion is fluid that has built up between the two thin membranes surrounding each lung, and the single most important step in figuring out what caused it is deciding whether that fluid is a transudate or an exudate. Transudates result from pressure imbalances in the circulatory system pushing fluid where it does not belong, while exudates result from disease or inflammation that has damaged the pleural membranes themselves. That distinction steers almost everything that follows: which tests to order, which diagnoses to consider, how aggressively to investigate, and how to treat.
How Fluid Normally Moves Through the Pleural Space
A healthy person has only a few milliliters of fluid between the two layers of the pleura. That thin film acts as a lubricant, letting the lungs slide smoothly against the chest wall during breathing. The fluid is constantly being produced and reabsorbed in a careful balance. It filters in through small blood vessels in the parietal pleura (the layer lining the chest wall), driven by pressure gradients between the capillaries and the pleural space.1PubMed. Pleural mechanics and fluid exchange Fluid leaves the space partly through reabsorption across the visceral pleura (the layer covering the lung) and partly through tiny openings called stomata in the parietal pleura that drain into lymphatic channels.2PubMed. Physiology and pathophysiology of pleural fluid turnover These lymphatic channels can ramp up their flow rate when extra fluid accumulates, acting as a built-in safety valve.3PubMed. Physiology and pathophysiology of pleural fluid turnover A pleural effusion forms only when something overwhelms that safety valve, either by flooding in more fluid than the lymphatics can handle or by damaging the drainage system itself.
The Transudate: A Plumbing Problem
A transudative effusion develops when the forces governing fluid movement across the pleura shift. The pleural membranes themselves are intact; the problem lies elsewhere in the body. Usually it is a matter of too much hydrostatic pressure pushing fluid out of blood vessels, too little protein in the blood to hold fluid in (low oncotic pressure), or both.4PubMed. Transudative effusions Think of it like a garden hose under too much pressure: the water leaks at every joint, not because the joints are broken but because the pressure is overwhelming them. Because the pleural surfaces are not damaged, fixing the underlying issue often causes the fluid to reabsorb on its own.5Clinics in Chest Medicine. Transudative Pleural Effusions
The most common cause is congestive heart failure, where a weakened heart backs up pressure into the veins of the lungs and chest. Liver cirrhosis is another major culprit. In cirrhosis, the liver’s scarred tissue raises pressure in the portal vein system, and small defects in the diaphragm allow abdominal fluid to migrate directly into the chest, a condition called hepatic hydrothorax.6PubMed Central. Hepatic hydrothorax Hepatic hydrothorax carries a grim prognosis, with a median survival of roughly eight to twelve months, and it can cause severe breathlessness even when the underlying liver disease seems stable.7PubMed Central. Hepatic hydrothorax Kidney disease, particularly nephrotic syndrome with its massive protein losses in urine, rounds out the big three causes of transudative effusions. In each case, the fluid itself is relatively bland: low in protein, low in cellular debris, and low in enzymes.
The Exudate: The Membrane Is Involved
An exudative effusion tells a different story. Here, disease has reached the pleural surface and disrupted its integrity. Inflammation makes mesothelial cells (the cells lining the pleura) release signaling molecules, including vascular endothelial growth factor (VEGF), which dramatically increases the permeability of nearby blood vessels and the pleural membrane itself.8European Respiratory Journal. Immunological mechanisms in pleural disease Proteins, immune cells, and other large molecules pour into the pleural space that would normally be kept out. At the same time, lymphatic drainage may be blocked by tumor cells, scar tissue, or swollen lymph nodes, further trapping fluid.9ERJ Open Research. Clinical overview of the physiology and pathophysiology of pleural fluid movement: a narrative review
The list of diseases that produce exudates is long and ranges from common to rare. Pneumonia is the leading infectious cause: bacteria spill into the pleural space and set off an aggressive inflammatory response, creating what is known as a parapneumonic effusion. If the infection worsens and pus accumulates, it becomes an empyema. Tuberculosis is a major cause of exudative effusions worldwide. Cancer is the other big category: lung cancer, breast cancer, and lymphoma are the tumors most frequently responsible for malignant pleural effusions, though almost any metastatic cancer can seed the pleura. Pulmonary embolism, autoimmune diseases like lupus and rheumatoid arthritis, and even certain medications can all produce exudates.
How Doctors Tell the Two Apart
The distinction between a transudate and an exudate almost always requires removing a sample of pleural fluid with a needle, a procedure called thoracentesis. The fluid is then tested against a set of thresholds known as Light’s criteria, developed in the 1970s and still the global standard. The criteria classify an effusion as an exudate if any one of the following is true: the pleural fluid protein divided by the serum protein is greater than 0.5; the pleural fluid lactate dehydrogenase (LDH) divided by the serum LDH is greater than 0.6; or the pleural fluid LDH exceeds two-thirds the upper limit of normal for serum LDH. If none of those thresholds is met, the fluid is classified as a transudate.
Light’s criteria are impressively sensitive for exudates, correctly catching them roughly 97 to 98 percent of the time across multiple validation studies.10PubMed. Reappraisal of the standard method (Light’s criteria) for identifying pleural exudates11ERJ Open Research. Revisiting Light’s criteria: a validated blood-free triple combination matches diagnostic accuracy in over 7000 patients Their specificity is lower, hovering around 70 to 80 percent, which means a meaningful fraction of true transudates get mislabeled as exudates.12PubMed. Reappraisal of the standard method (Light’s criteria) for identifying pleural exudates That trade-off is deliberate: missing an exudate (and therefore missing cancer, tuberculosis, or infection) is far more dangerous than sending a heart-failure patient through a few extra tests.
Researchers have looked for alternatives. A recent large study of over seven thousand patients found that a blood-free triple combination using pleural fluid protein, LDH, and cholesterol levels alone matched the diagnostic accuracy of Light’s criteria while correctly reclassifying about one in five transudates that Light’s criteria had mislabeled.13ERJ Open Research. Revisiting Light’s criteria: a validated blood-free triple combination matches diagnostic accuracy in over 7000 patients Still, for now, Light’s criteria remain the dominant tool in clinical practice.
The Pseudoexudate Problem
One of the most well-known pitfalls in pleural fluid analysis involves patients with heart failure who have been treated with diuretics before their fluid is sampled. Diuretics pull water out of the body, but the protein and LDH already in the pleural space do not leave as quickly. This concentrates those molecules, pushing their levels above the Light’s criteria thresholds and making a true transudate look like an exudate. Clinicians call this a “pseudoexudate.”
The phenomenon was documented in a classic study that tracked heart-failure patients through treatment: pleural fluid protein rose from an average of about 2.2 g/dL before treatment to 3.2 g/dL after diuresis, and in three of the patients studied, fluid that had clearly been a transudate on initial testing met exudate criteria after weight loss from diuretic therapy.14PubMed. Treatment of congestive heart failure. Its effect on pleural fluid chemistry A larger study confirmed the pattern, showing that protein concentrations climbed from roughly 23 g/L to 33 g/L and LDH from about 177 U/L to 288 U/L over the course of treatment.15PubMed. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure
When a doctor suspects a pseudoexudate, several rescue tests can help. The serum-to-pleural-fluid albumin gradient is one: if the difference between serum albumin and pleural fluid albumin exceeds 1.2 g/dL, the effusion is likely a transudate regardless of what Light’s criteria say. A review of heart-failure effusions found that Light’s criteria misclassified about 29 percent of transudates from heart failure, and applying the albumin gradient correctly reclassified roughly 80 percent of those misidentified cases.16PubMed Central. Cardiac related pleural effusions: a narrative review Another powerful tool is measuring NT-proBNP, a hormone released by a stressed heart, directly in the pleural fluid. A meta-analysis of twelve studies found that a pleural fluid NT-proBNP level above 1,500 pg/mL had a sensitivity and specificity both above 90 percent for identifying heart-failure-related effusions.17PubMed Central. Cardiac related pleural effusions: a narrative review Either test can spare a patient from unnecessary invasive procedures like pleural biopsy when the real answer is simply that diuretics concentrated a benign fluid.
Can Imaging Tell Transudates from Exudates Without a Needle?
It would be convenient if a CT scan or ultrasound could distinguish the two types before anyone sticks a needle in. The honest answer is that imaging offers useful clues but cannot replace fluid analysis. On CT, exudative effusions tend to appear denser, measured in Hounsfield units (HU). Multiple studies have found that exudates have significantly higher average HU values than transudates, with one large study reporting median values of about 13 HU for exudates versus about 5 HU for transudates.18PubMed Central. Diagnostic accuracy of thoracic CT to differentiate transudative from exudative pleural effusion prior to thoracentesis Using a cutoff around 8 to 11 HU, CT can achieve roughly 85 to 92 percent sensitivity for picking out exudates.19PubMed Central. Efficacy of CT in diagnosis of transudates and exudates in patients with pleural effusion20Imaging in Medicine. Efficacy Of ultrasonography and computed tomography in differentiating transudate from exudate in patients with pleural effusion
The problem is overlap. Many effusions land in a grey zone where their density could go either way. Imaging signs like pleural thickening, pleural nodules, and fluid loculation (pockets of trapped fluid) lean heavily toward exudates and have very high specificity, but not every exudate shows those features, especially early in its course.21Imaging in Medicine. Efficacy Of ultrasonography and computed tomography in differentiating transudate from exudate in patients with pleural effusion So CT can raise or lower suspicion, and it is essential for planning where and how to sample the fluid, but it does not replace a thoracentesis.
Thoracentesis Safety and What to Expect
Thoracentesis is a straightforward bedside procedure. A needle or small catheter is inserted between the ribs under local anesthesia, and fluid is drawn off. It can be both diagnostic (getting a sample to analyze) and therapeutic (relieving the pressure on the lung and making it easier to breathe). Ultrasound guidance has made the procedure much safer. In one study of over 440 patients with cancer-related effusions, pneumothorax (air leaking into the chest from the procedure) occurred in under 1 percent of ultrasound-guided cases compared to about 9 percent of cases done without ultrasound.22PubMed Central. Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer All three patients who needed a chest tube for their pneumothorax in that study had undergone the procedure without ultrasound.
In a larger series of over 900 ultrasound-guided thoracenteses, the overall complication rate was low: pneumothorax in about 2.5 percent, pain in about 3 percent, and rare events like bleeding or re-expansion pulmonary edema in well under 1 percent. Removing more than about a liter of fluid in a single session was linked to a higher chance of complications.23PubMed. Ultrasound-guided thoracentesis: is it a safer method? For most patients, the procedure takes ten to twenty minutes and the relief from breathlessness can be dramatic.
Narrowing the Diagnosis Once You Know It Is an Exudate
Classifying an effusion as exudative is the starting point, not the finish line. The fluid then undergoes further testing to determine why the pleura is inflamed. Cell counts and differentials can point toward infection (lots of white blood cells, especially neutrophils), tuberculosis (a predominance of lymphocytes), or malignancy (atypical cells). Cultures and Gram stains are run to look for bacteria.
For suspected cancer, cytology is the workhorse test, where a pathologist examines the fluid under a microscope looking for malignant cells. Sensitivity varies by tumor type: one study found overall sensitivity around 67 percent, climbing to about 88 percent for adenocarcinomas but dropping to about 46 percent for mesothelioma.24PubMed. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience When cytology alone falls short, combining it with cell block analysis and closed pleural biopsy can push the diagnostic yield above 85 percent.25PubMed Central. A comparative diagnostic yield among cytologic examination, cell block and closed pleural biopsy in exudative pleural effusion
For tuberculosis, measuring adenosine deaminase (ADA) in the fluid has become a cornerstone diagnostic tool, especially in areas where TB is common. A systematic meta-analysis found that ADA had a pooled sensitivity of 92 percent and specificity of 90 percent for diagnosing tuberculous pleural effusions.26PubMed Central. Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis ADA is cheap, fast, and widely available, making it particularly valuable in resource-limited settings where TB culture results take weeks.
Other specialized tests come into play in specific clinical situations. High amylase in the fluid raises suspicion for pancreatitis or esophageal rupture. Elevated triglycerides point toward a chylothorax, where lymphatic fluid rich in dietary fats leaks into the chest, often from trauma or lymphoma damaging the thoracic duct.27PubMed. Useful clinical biological markers in diagnosis of pleural effusions in children
How Treatment Differs
For transudative effusions, treatment focuses almost entirely on the underlying systemic condition. Optimizing heart failure with diuretics, vasodilators, and sometimes device therapy will reduce the fluid load. Managing cirrhosis with salt restriction, diuretics, and ultimately liver transplant evaluation targets hepatic hydrothorax. Dialysis can resolve effusions caused by kidney failure. If the underlying disease responds, many transudates resolve without ever needing to be drained, and repeated thoracentesis alone is usually enough for symptom relief in the interim.
Exudative effusions demand more targeted and often more aggressive treatment because the pleura itself is diseased. Parapneumonic effusions may require antibiotics alone for simple cases, but if the fluid becomes complicated (low pH, low glucose, high LDH) or progresses to empyema, chest tube drainage and sometimes surgical intervention become necessary. Cancer-related effusions present a management challenge because they tend to recur quickly after drainage. Two main options exist for recurrent malignant effusions: pleurodesis, where a substance like talc is instilled to intentionally scar the two pleural layers together so fluid cannot re-accumulate, and indwelling pleural catheters (IPCs), which are tunneled tubes left in place so the patient or a caregiver can drain fluid at home on a regular schedule.28PubMed Central. Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions
A randomized trial comparing the two approaches found that patients with IPCs spent fewer total days in the hospital (a median of 10 versus 12 days) and had substantially fewer effusion-related hospital days (a median of 1 versus 4 days).29JAMA. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial They were also far less likely to need repeat invasive procedures on the same side. However, the two approaches offered similar improvements in breathlessness and quality of life, and IPCs carry a higher risk of skin infection around the catheter site.30PubMed. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions The choice between them hinges on a patient’s overall condition, life expectancy, willingness to manage a catheter at home, and what local expertise is available.
Drug-Induced Effusions
A sometimes-overlooked cause of exudative effusions is medication. Dozens of drugs across multiple categories have been linked to pleural inflammation and fluid accumulation. In psychiatry, valproic acid and dantrolene are among the more frequently reported offenders, and cases have also been tied to fluoxetine, clozapine, and trimipramine.31European Respiratory Review. Drug-induced eosinophilic pleural effusion Cardiac and internal medicine drugs including warfarin, diltiazem, and simvastatin appear on the list, as do certain antibiotics like nitrofurantoin and daptomycin.32European Respiratory Review. Drug-induced eosinophilic pleural effusion
A distinctive clue to drug-induced pleural disease is the presence of a high proportion of eosinophils in the fluid. The challenge is that patients are often on multiple medications, making it difficult to pin the effusion on a single drug. The gold standard for confirming the diagnosis is stopping the suspected medication and watching for resolution, then ideally seeing the effusion return if the drug is restarted, though rechallenge is understandably not always performed. For anyone who develops an unexplained exudative effusion, a thorough medication review is a necessary step that is sometimes skipped.
Special Considerations in Children
Pleural effusions in children follow somewhat different patterns than those in adults. The causes, typical fluid characteristics, and appropriate diagnostic approaches can all differ.33PubMed. Common pleural effusions in children Parapneumonic effusions remain the most common type in pediatric patients, and they are overwhelmingly exudative. Heart failure causing transudative effusions does occur in children but is proportionally less common than in adults, and when it happens it tends to be related to congenital heart disease or cardiomyopathy rather than the coronary artery disease and chronic conditions that dominate in older patients. Malignant effusions in children, while rare, are more likely to come from lymphomas and leukemias than from solid tumors. The thresholds used in Light’s criteria were developed and validated primarily in adult populations, and clinicians caring for pediatric patients often weigh the clinical picture more heavily alongside fluid analysis when interpreting borderline results.